🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study was to investigate the safety and tolera...
Status
Completed
Location
Multiple Locations
Start Date
2002-08
Trial ID
NCT00224783
The purpose of this study was to assess the safety, effectiveness, and immu...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-06-14
Trial ID
NCT04886154
The goal of this study is to compare ferrous salt and liposomal iron for th...
Status
Not Yet Recruiting
Location
Hospital General de México "Eduardo Liceaga"
Start Date
2026-05-01
Trial ID
NCT07556731
This study will assess the safety, tolerability, and efficacy of dapsone in...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT01785836
Treatments Being Tested
This study will be an open-label, randomized, 3-way, 6-sequence crossover s...
Status
Completed
Location
Multiple Locations
Start Date
2010-12-01
Trial ID
NCT01249131
Treatments Being Tested
Substudy A: The study aims to learn about the safety and effects of two new...
Status
Completed
Location
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Start Date
2023-03-09
Trial ID
NCT05788237
The goal of this study is to compare two approaches for commencing pharmaco...
Status
Withdrawn
Location
NYU Langone Health
Start Date
2023-11-01
Trial ID
NCT05481112
Treatments Being Tested
To evaluate the long-term effects of oral citicoline, vitamins A, B, C and ...
Status
Completed
Location
University of Naples Federico II
Start Date
2022-01-10
Trial ID
NCT06355765
Treatments Being Tested
Piperaquine tablets (coated) + OZ439 granules + TPGS granules will be co-ad...
Status
Completed
Location
Richmond Pharmacology Limited
Start Date
2013-04
Trial ID
NCT01853475
Treatments Being Tested
The objective of this extension study is the initial assessment of safety a...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03-29
Trial ID
NCT02690181
Treatments Being Tested